Del-AHNAK2mut was closely correlated with the higher TMB and NAL level and activation of the NK cells, T cells, and IFN-γ signaling, which in turn initiate a therapeutic immune response in NSCLC. The gene discussed is NPL; the disease is non-small cell lung carcinoma.